Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Anti-Infective Vaccines Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Anti-Infective Vaccines Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Inactivated vaccines
      • 1.3.3 Conjugate vaccines
      • 1.3.4 Live/attenuated vaccines
    • 1.4 Market Segment by Application
      • 1.4.1 Global Anti-Infective Vaccines Market Share by Application (2019-2025)
      • 1.4.2 Bacterial diseases
      • 1.4.3 Viral diseases
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Anti-Infective Vaccines Market Size
      • 2.1.1 Global Anti-Infective Vaccines Revenue 2014-2025
      • 2.1.2 Global Anti-Infective Vaccines Sales 2014-2025
    • 2.2 Anti-Infective Vaccines Growth Rate by Regions
      • 2.2.1 Global Anti-Infective Vaccines Sales by Regions 2014-2019
      • 2.2.2 Global Anti-Infective Vaccines Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Anti-Infective Vaccines Sales by Manufacturers
      • 3.1.1 Anti-Infective Vaccines Sales by Manufacturers 2014-2019
      • 3.1.2 Anti-Infective Vaccines Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Anti-Infective Vaccines Revenue by Manufacturers (2014-2019)
      • 3.2.2 Anti-Infective Vaccines Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Anti-Infective Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.3 Anti-Infective Vaccines Price by Manufacturers
    • 3.4 Key Manufacturers Anti-Infective Vaccines Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Anti-Infective Vaccines Market
    • 3.6 Key Manufacturers Anti-Infective Vaccines Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Inactivated vaccines Sales and Revenue (2014-2019)
      • 4.1.2 Conjugate vaccines Sales and Revenue (2014-2019)
      • 4.1.3 Live/attenuated vaccines Sales and Revenue (2014-2019)
    • 4.2 Global Anti-Infective Vaccines Sales Market Share by Type
    • 4.3 Global Anti-Infective Vaccines Revenue Market Share by Type
    • 4.4 Anti-Infective Vaccines Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Anti-Infective Vaccines Sales by Application

    6 United States

    • 6.1 United States Anti-Infective Vaccines Breakdown Data by Company
    • 6.2 United States Anti-Infective Vaccines Breakdown Data by Type
    • 6.3 United States Anti-Infective Vaccines Breakdown Data by Application

    7 European Union

    • 7.1 European Union Anti-Infective Vaccines Breakdown Data by Company
    • 7.2 European Union Anti-Infective Vaccines Breakdown Data by Type
    • 7.3 European Union Anti-Infective Vaccines Breakdown Data by Application

    8 China

    • 8.1 China Anti-Infective Vaccines Breakdown Data by Company
    • 8.2 China Anti-Infective Vaccines Breakdown Data by Type
    • 8.3 China Anti-Infective Vaccines Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Anti-Infective Vaccines Breakdown Data by Company
    • 9.2 Rest of World Anti-Infective Vaccines Breakdown Data by Type
    • 9.3 Rest of World Anti-Infective Vaccines Breakdown Data by Application
    • 9.4 Rest of World Anti-Infective Vaccines Breakdown Data by Countries
      • 9.4.1 Rest of World Anti-Infective Vaccines Sales by Countries
      • 9.4.2 Rest of World Anti-Infective Vaccines Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Emergent BioDefense Operations Lansing Inc.
      • 10.1.1 Emergent BioDefense Operations Lansing Inc. Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Anti-Infective Vaccines
      • 10.1.4 Anti-Infective Vaccines Product Introduction
      • 10.1.5 Emergent BioDefense Operations Lansing Inc. Recent Development
    • 10.2 Sanofi Pasteur
      • 10.2.1 Sanofi Pasteur Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Anti-Infective Vaccines
      • 10.2.4 Anti-Infective Vaccines Product Introduction
      • 10.2.5 Sanofi Pasteur Recent Development
    • 10.3 Merck & Co.
      • 10.3.1 Merck & Co. Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Anti-Infective Vaccines
      • 10.3.4 Anti-Infective Vaccines Product Introduction
      • 10.3.5 Merck & Co. Recent Development
    • 10.4 MedImmune LLC
      • 10.4.1 MedImmune LLC Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Anti-Infective Vaccines
      • 10.4.4 Anti-Infective Vaccines Product Introduction
      • 10.4.5 MedImmune LLC Recent Development
    • 10.5 Novartis Vaccines
      • 10.5.1 Novartis Vaccines Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Anti-Infective Vaccines
      • 10.5.4 Anti-Infective Vaccines Product Introduction
      • 10.5.5 Novartis Vaccines Recent Development
    • 10.6 Diagnostics Ltd.
      • 10.6.1 Diagnostics Ltd. Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Anti-Infective Vaccines
      • 10.6.4 Anti-Infective Vaccines Product Introduction
      • 10.6.5 Diagnostics Ltd. Recent Development
    • 10.7 Intercell Biomedical
      • 10.7.1 Intercell Biomedical Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Anti-Infective Vaccines
      • 10.7.4 Anti-Infective Vaccines Product Introduction
      • 10.7.5 Intercell Biomedical Recent Development
    • 10.8 MassBiologics
      • 10.8.1 MassBiologics Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Anti-Infective Vaccines
      • 10.8.4 Anti-Infective Vaccines Product Introduction
      • 10.8.5 MassBiologics Recent Development
    • 10.9 Barr Labs, Inc.
      • 10.9.1 Barr Labs, Inc. Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Anti-Infective Vaccines
      • 10.9.4 Anti-Infective Vaccines Product Introduction
      • 10.9.5 Barr Labs, Inc. Recent Development
    • 10.10 Organon Teknika Co.
      • 10.10.1 Organon Teknika Co. Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Anti-Infective Vaccines
      • 10.10.4 Anti-Infective Vaccines Product Introduction
      • 10.10.5 Organon Teknika Co. Recent Development
    • 10.11 GlaxoSmithKline Biologicals
    • 10.12 CSL Ltd.
    • 10.13 ID Biomedical Co.
    • 10.14 Protein Sciences Co.
    • 10.15 Wyeth Pharmaceuticals, Inc.
    • 10.16 Berna Biotech

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Anti-Infective Vaccines Sales Channels
      • 11.2.2 Anti-Infective Vaccines Distributors
    • 11.3 Anti-Infective Vaccines Customers

    12 Market Forecast

    • 12.1 Global Anti-Infective Vaccines Sales and Revenue Forecast 2019-2025
    • 12.2 Global Anti-Infective Vaccines Sales Forecast by Type
    • 12.3 Global Anti-Infective Vaccines Sales Forecast by Application
    • 12.4 Anti-Infective Vaccines Forecast by Regions
      • 12.4.1 Global Anti-Infective Vaccines Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Anti-Infective Vaccines Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Anti-infective vaccines are the most effective public health measure taken to fight infectious diseases.
      In 2019, the market size of Anti-Infective Vaccines is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-Infective Vaccines.

      This report studies the global market size of Anti-Infective Vaccines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Anti-Infective Vaccines sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Emergent BioDefense Operations Lansing Inc.
      Sanofi Pasteur
      Merck & Co.
      MedImmune LLC
      Novartis Vaccines
      Diagnostics Ltd.
      Intercell Biomedical
      MassBiologics
      Barr Labs, Inc.
      Organon Teknika Co.
      GlaxoSmithKline Biologicals
      CSL Ltd.
      ID Biomedical Co.
      Protein Sciences Co.
      Wyeth Pharmaceuticals, Inc.
      Berna Biotech

      Market Segment by Product Type
      Inactivated vaccines
      Conjugate vaccines
      Live/attenuated vaccines

      Market Segment by Application
      Bacterial diseases
      Viral diseases

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Anti-Infective Vaccines status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Anti-Infective Vaccines manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Anti-Infective Vaccines are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now